Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trialHarold Atkins, Mark S. Freedman, Dean Fergusson et al.|The Lancet|2016Cited by 327
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosisSimon Thebault, Mark S. Freedman, Hyunwoo Lee et al.|Annals of Clinical and Translational Neurology|2020Cited by 34
Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot studyLisa A.S. Walker, Mark S. Freedman, Jason A. Berard et al.|Multiple Sclerosis and Related Disorders|2013Cited by 12
Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantationJason A. Berard, Lisa A.S. Walker, Marjorie A. Bowman et al.|Journal of the Neurological Sciences|2013Cited by 11
Physiological fitness in people with advanced multiple sclerosisArthur R. Chaves, Lara A. Pilutti, Thomas H. Edwards et al.|Multiple Sclerosis and Related Disorders|2024Cited by 4